Virus-Based Nanoreactors with GALT Activity for Classic Galactosemia Therapy

被引：13

作者：

Gama, Pedro ^{[1
]}

Cadena-Nava, Ruben D. ^{[1
]}

Juarez-Moreno, Karla ^{[1
]}

Perez-Robles, Javier ^{[1
]}

Vazquez-Duhalt, Rafael ^{[1
]}

机构：

[1] Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Dept Bionanotechnol, Ensenada, Baja California, Mexico

来源：

CHEMMEDCHEM | 2021年 / 16卷 / 09期

关键词：

bio-nanoreactor; classic galactosemia; galactose-1-phosphate uridylyl-transferase; GALT; virus-like nanoparticles;

D O I：

10.1002/cmdc.202000999

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Enzymatic nanoreactors were obtained by galactose-1-phosphate uridylyl-transferase (GALT) encapsulation into plant virus capsids by a molecular self-assembly strategy. The aim of this work was to produce virus-like nanoparticles containing GALT for an enzyme-replacement therapy for classic galactosemia. The encapsulation efficiency and the catalytic constants of bio-nanoreactors were determined by using different GALT and virus coat protein ratios. The substrate affinity of nanoreactors was slightly lower than that of the free enzyme; the activity rate was 16 % of the GALT free enzyme. The enzymatic nanoreactors without functionalization were internalized into different cell lines including fibroblast and kidney cells, but especially into hepatocytes. The enzymatic nanoreactors are an innovative enzyme preparation with potential use for the treatment of classic galactosemia.

引用

页码：1438 / 1445

页数：8

共 50 条

[41] Gene delivery and gene therapy with herpes simplex virus-based vectors
Latchman, DS
GENE, 2001, 264 (01) : 1 - 9
[42] Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy
Kim, Youra
Clements, Derek R.
Sterea, Andra M.
Jang, Hyun Woo
Gujar, Shashi A.
Lee, Patrick W. K.
VIRUSES-BASEL, 2015, 7 (12): : 6506 - 6525
[43] PROSPECTS FOR VIRUS-BASED GENE-THERAPY FOR CYSTIC-FIBROSIS
FLOTTE, TR
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1993, 25 (01) : 37 - 42
[44] Adeno-associated virus-based vectors and their application for gene therapy
Serra, C
Zentilin, L
Giacca, M
MINERVA BIOTECNOLOGICA, 1996, 8 (03) : 183 - 190
[45] The state of the art of adeno-associated virus-based vectors in gene therapy
Renata dosSantos Coura
Nance Beyer Nardi
Virology Journal, 4
[46] The state of the art of adeno-associated virus-based vectors in gene therapy
Coura, Renata dos Santos
Nardi, Nance Beyer
VIROLOGY JOURNAL, 2007, 4 (1)
[47] Herpes simplex virus-based nerve targeting gene therapy in pain management
Goss, James R.
Krisky, David
Wechuck, James
Wolfe, Darren
JOURNAL OF PAIN RESEARCH, 2014, 7 : 71 - 79
[48] Restoring galactose metabolism without restoring GALT rescues both compromised survival in larvae and an adult climbing deficit in a GALT-null D. Melanogaster model of classic galactosemia
Daenzer, Jennifer M. I.
Druss, Jared J.
Fridovich-Keil, Judith L.
JOURNAL OF INHERITED METABOLIC DISEASE, 2024, 47 (05) : 991 - 1000
[49] Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
Ning, Jianfang
Wakimoto, Hiroaki
FRONTIERS IN MICROBIOLOGY, 2014, 5
[50] Optimizing virus-based expression systems
Artinger, Michael
Kemp, Christopher W.
Pushko, Peter
Olszowy, Michael W.
Genetic Engineering and Biotechnology News, 2015, 35 (01): : 28 - 29

← 1 2 3 4 5 →